Showing results (1-10 of 213) with videos related to
Sort By:
Pageof 22
Annals of Epidemiology|June 14, 2020
Gender and lung cancer-SEER-based analysisYaakov Tolwin, Roni Gillis, Nir PeledClinical Lung Cancer|July 16, 2019
Increased Incidence of Lung Cancer Among Patients With Superficial Transitional Cell Carcinoma: A Potential Risk Cohort for Lung Cancer ScreeningYaakov Tolwin, Roni Gillis, Inbar Nardi Agmon, et al.European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie|May 21, 2024
Complications and survival rates of subtrochanteric fractures are similar between short and long intramedullary nail fixation and independent of weight-bearingDaniel Cohen, Yaakov Tolwin, Michael Toybenshlak, et al.Lung Cancer (Amsterdam, Netherlands)|January 24, 2021
The impact of osimertinib' line on clonal evolution in EGFRm NSCLC through NGS-based liquid biopsy and overcoming strategies for resistanceVered Fuchs, Laila Roisman, Waleed Kian, et al.Breathe (Sheffield, England)|June 8, 2018
Assembly 11: thoracic oncologyClementine Bostantzoglou, Nir PeledLung Cancer (Auckland, N.Z.)|May 30, 2017
Exhaled breath analysis for the early detection of lung cancer: recent developments and future prospectsInbar Nardi-Agmon, Nir PeledHarefuah|October 21, 2015
[LUNG CANCER TREATMENT IN 2015: ADVANCES AND FUTURE OUTLOOK]Nir Peled, Anna Belilovski RozenblumCancers|May 4, 2026
The Impact of Minimal Residual Disease (MRD) Testing on the Decision-Making Process in Non-Small-Cell Lung Cancer (NSCLC)Roni Gillis, Tamar Zahavi, Nir Peled, et al.Patterns (New York, N.Y.)|July 15, 2026
From matching to facilitation: Reframing AI's role in clinical trial enrollmentAdar Yaacov, Einat Levi, Nir PeledMedicine|January 26, 2017
Not only for melanoma. Subcutaneous pseudoprogression in lung squamous-cell carcinoma treated with nivolumab: A case reportMichal Sarfaty, Assaf Moore, Elizabeth Dudnik, et al.Pageof 22